Cardiac Surgery

The Cardiac and Great Vessel Surgery Department is described by the hospital as Anhui's largest integrated clinical, teaching and research center for cardiac and great-vessel diseases. It is the institution of the chair-elect of the Anhui branch of the Chinese Medical Association's cardiac and great-vessel surgery society, an Anhui key specialty, a key discipline of Anhui Medical University and an Anhui peak discipline. In 2022 the National Regional Cardiovascular Medical Center—Anhui Hospital of Beijing Anzhen Hospital, Capital Medical University—was approved. The department has 137 medical and technical staff: ten with full senior titles, 16 associate senior, 45 intermediate and 66 junior. All physicians have at least a master's degree and nearly one third hold doctorates. It has three wards and one ICU: Jixi Road Ward 1, High-tech Campus Wards 2 and 3, and the High-tech cardiac surgery ICU. The department reports 146 beds, eight cardiopulmonary bypass machines, two ECMO machines and more than 2,500 operations annually. It treats coronary disease, thoracic great-vessel disease, valvular heart disease, end-stage heart disease, congenital heart disease, atrial fibrillation, cardiac myxoma, pericarditis and other cardiac and great-vessel conditions. Since 2022 it reports 118 papers, including 32 SCI-indexed and 86 Chinese-language papers; one National Natural Science Foundation project; one Anhui science and technology progress third prize; three Anhui clinical medical research translation projects; and one monograph published with a department member as associate editor. It has participated in six industry-initiated clinical studies, including studies with completed enrollment, and sends one or two staff members each year for further training at advanced cardiovascular centers in China or abroad.